Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost-effectiveness of CYP2D6 and CYP2C19 Genotyping in Psychiatric Patients in Curacao

NCT02713672 is registered in ClinicalTrials.gov with GGZ Centraal as lead sponsor.

NCT NCT02713672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02713672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost-effectiveness of CYP2D6 and CYP2C19 Genotyping in Psychiatric Patients in Curacao
Lead sponsor
GGZ Centraal
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
June 30, 2015
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cyp2d6, psychiatric patients